PR: Tubilux selects TraceLink to achieve EU FMD compliance

TraceLink Inc., the world’s largest track and trace network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced that Tubilux has selected its serialization solutions to help its 30+ European pharmaceutical manufacturing customers comply with the rapidly approaching serialization deadlines for the EU Falsified Medicines Directive (FMD).

Based in Italy, Tubilux is a pharmaceutical contract manufacturer that provides services to major and emerging pharmaceutical companies and specialises in ophthalmic products, including the manufacture of ointments, gels and eye drops for a wide range of eye disorders. Tubilux selected the TraceLink Life Sciences Cloud to enable its customers to meet the EU FMD regulations on-time, at the lowest cost and least risk to its product supply. By leveraging TraceLink’s network tenant architecture, Tubilux can eliminate the complexity and costs associated with point-to-point integrations for its EU pharmaceutical manufacturing customers.

“Our long-standing history in the international pharmaceutical and contract manufacturing industry has enabled Tubilux to become the benchmark in ophthalmology and preferred business partner for a number of Italian and international companies. In order to preserve our valued client relationships, we chose TraceLink for its market leadership and ability to help us seamlessly provide serialization through a simple integration and wide breadth of interoperability with our partners,” said a Tubilux spokesperson. “With over 30 clients, we could not afford to lose time and resources by establishing individual point-to-point connections with each customer. TraceLink’s network approach instantly transformed our serialization project into a much easier and more manageable process.”

“EU FMD compliance is becoming a stark reality for companies that need to have serialization in place by the February 2019 deadline. The TraceLink Life Sciences Cloud platform provides companies with an easy and fast path directly into the EU Hub,” said Shabbir Dahod, president and CEO of TraceLink. “Tubilux values our deep expertise on EU compliance and chose TraceLink to simplify the serialization process while reducing costs and minimising complexities with data exchange. We look forward to partnering with Tubilux to help ensure EU FMD compliance for its customers in Europe.”

TraceLink has already processed EU compliance reports for more than 660,000 units of product into the European hub, nearly 18 months ahead of deadline. The TraceLink European Union Compliance module supports traceability reporting requirements from a single platform, providing customers with a tested integration to the European hub for reporting information about their product master data, serialised product pack data, and status changes for products targeted for distribution across all Member States.

About TraceLink

TraceLink is the World’s Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte’s Technology Fast 500 (ranked number 149 in 2016), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost